JPMorgan to Advise ImClone
ImClone Systems, the biotechnology company which rebuffed a $60-per-share takeover offer from Bristol-Myers Squibb, said on Thursday it hired JPMorgan Chase as its financial adviser. 3 months ago
DealBook - New York Times Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook